找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Artificial Oxygen Carrier; Its Frontline Koichi Kobayashi (Chief Professor of Surgery),Eish Conference proceedings 2005 Springer-Verlag Tok

[復(fù)制鏈接]
41#
發(fā)表于 2025-3-28 17:09:04 | 只看該作者
42#
發(fā)表于 2025-3-28 20:41:08 | 只看該作者
Isolation and Culture of Skin Fibroblastsing a hemoglobin (Hb)-based oxygen carrier. In this chapter, we have summarized the characteristics and performances of Hb-vesicles (HbV) that have been developed on the basis of molecular assembly. Collaborative in vitro and in vivo studies have revealed sufficient safety and efficacy of HbV.
43#
發(fā)表于 2025-3-28 23:46:29 | 只看該作者
44#
發(fā)表于 2025-3-29 04:19:03 | 只看該作者
45#
發(fā)表于 2025-3-29 07:23:06 | 只看該作者
978-4-431-54636-8Springer-Verlag Tokyo 2005
46#
發(fā)表于 2025-3-29 12:24:26 | 只看該作者
Safety and Efficacy of Hemoglobin-Vesicles and Albumin-Hemes,s have been selected from the viewpoints of safety, efficacy, and cost performance. One is Hemoglobin-vesicles (HbV) and the other is albumin-heme (rHSA-heme). This chapter summarizes our video presentation that introduced the recent results of our research into HbV and rHSA-heme.
47#
發(fā)表于 2025-3-29 18:35:43 | 只看該作者
Hemoglobin-Vesicles (HbV) as Artificial Oxygen Carriers,ing a hemoglobin (Hb)-based oxygen carrier. In this chapter, we have summarized the characteristics and performances of Hb-vesicles (HbV) that have been developed on the basis of molecular assembly. Collaborative in vitro and in vivo studies have revealed sufficient safety and efficacy of HbV.
48#
發(fā)表于 2025-3-29 22:17:19 | 只看該作者
Intravascular Microbubbles: An Ultra-Effective Means of Transporting Oxygen,able to transport physiologically significant amounts of oxygen in animal experiments. Thus, the treatment sustained life in rats and pigs with potentially fatal erythrocytopenia caused by hemorrhage and hemodilution, and adequate oxygenation was preserved in severe right-to-left circulatory shunts caused by partial airway blockage in pigs.
49#
發(fā)表于 2025-3-29 23:57:52 | 只看該作者
50#
發(fā)表于 2025-3-30 06:44:50 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-24 11:37
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
陆川县| 绥芬河市| 古丈县| 迁西县| 陆丰市| 衡山县| 吉首市| 岳普湖县| 敦化市| 滦南县| 威海市| 永康市| 右玉县| 盐津县| 蓬莱市| 白河县| 太仆寺旗| 类乌齐县| 东平县| 儋州市| 玛纳斯县| 深泽县| 无锡市| 万州区| 探索| 多伦县| 六盘水市| 朝阳市| 南昌县| 辉县市| 蓬溪县| 布尔津县| 清水河县| 广德县| 长兴县| 德安县| 满洲里市| 和林格尔县| 龙山县| 五指山市| 兴山县|